Fida Neo

In-solution kinetics:
No more restrictions

Expand your capacities

One technology to measure:
  • Affinity (KD)

  • Kinetics (kon & koff )

  • Quantity

  • 8 Quality Control Parameters per data point:
    Size, Aggregation, Viscosity, Stickiness, PDI, Labelling Quality, PDB Correlator & Sample Loss

Discovery Call

Expand your capacities

One technology to measure:
  • Affinity (KD)

  • Kinetics (KON & KOFF)

  • Quantity

  • 8 Quality Control Parameters per data point: 
Size, Aggregation, Viscosity, Stickiness, PDI, Labelling Quality, PDB Correlator & Sample Loss

Measure: Affinity, kinetics, quantity & quality

Fida Neo delivers:
  • Absolute size measurement (Rh)
  • BRIC (Binding Related Intensity Change measurement)
  • Affinity (KD)

  • Kinetics (KON & KOFF)

  • Quantity
Providing you with extensive data set and research flexibility. 
All based on first principle, absolute measurements. Read more on technology

Benefit from 8 Quantitative Quality Control Parameters

8 embedded quality control features and a brand new Quality Control Module, deliver an overview on quality of each sample tested. Thanks to our newest update you can easily create A Quality Control Report to each of your essays, ensuring data consistency, boosting efficiency. Easily implemented in your workflow.

Used absolute size measurement (Rh)

Use FIDA to discover what triggers changes of your molecule or construct, based on direct measurement of the hydrodynamic radius. It detects size changes of less than 5% in hydrodynamic radius, has a dynamic size ranging from 0.5 to 500nm Rh and can detect affinities from pM to mM. These features make Fida Neo a perfect tool for affinity assays, as well as stoichiometry validation and oligometric/structural state of proteins

5%

size change detection

0.5-500nm

Dynamic Range

pM-mM

Affinities

sec-hrs

kinetics

Measure: Affinity, kinetics,
quantity & quality

Fida Neo delivers:
  • Absolute size measurement (Rh)
  • BRIC (Binding Related Intensity Change measurement)
  • Affinity (KD)

  • Kinetics (kon & koff )

  • Quantity
Providing you with extensive data set and research flexibility. All based on first principle, absolute measurements. Read more on technology.

Benefit from 8 Quantitative Quality
Control Parameters

8 embedded quality control features and a brand new Quality Control Module, deliver an overview on quality of each sample tested. Thanks to our newest update you can easily create A Quality Control Report to each of your essays, ensuring data consistency, boosting efficiency. Easily implemented in your workflow.

Used absolute size measurement (Rh)

Use FIDA to discover what triggers changes of your molecule or construct, based on direct measurement of the hydrodynamic radius. It detects size changes of less than 5% in hydrodynamic radius, has a dynamic size ranging from 0.5 to 500nm Rh and can detect affinities from pM to mM. These features make Fida Neo a perfect tool for affinity assays, as well as stoichiometry validation and oligometric/structural state of proteins

5%

size change detection

0.5-500nm

Dynamic Range

pM-mM

Affinities

sec-hrs

kinetics

Work in-solution:

with no environmental restrictions

Fida Neo allows users to work under native conditions, such as serum, plasma, cell lysate or fermentation media. Having no restrictions on the matrix type unlocks the opportunity to run assays in environmentally relevant conditions.

  • Seamlessly operate in complex matrices including fermentation media, plasma or serum.

Work in solution:

avoid non-specific binding

FIDA, as an non-surfaced, in solution technology keeps all the binding sites available for interaction. In practice, such an approach translates to:

  • No steric hindrance to high density immobilised ligands
  • No non-specific binding issues
  • No risk of re-binding

Free yourself from restrictions:

any detergents, ionic strengths, temperature, pH and others

Fida Neo has no restrictions related to detergent usage, ionic strength, temperature or sample pH. This eliminates common research restrictions, boosts creative biophysical capability and allows you easily to produce environmentally relevant findings.

  • Minimise assay development time
  • Expand the scope of biological systems you can characterise
  • Increase environmental relevance

No need for surface regeneration

With FIDA there is no surface chemistry involved.

  • Eliminate risk of denaturing immobilised protein
  • Rapidly determine slow off rates for high affinity interactions
2nd slide3rd slide4th slide
An autosampler
2 x 96 well plates & 2 x 50 vials
1
Wide sensitivity range: picomolar to millimolar
3
Temperature controls:
  • Capillary chamber
    15-55°C
  • Autosampler
    5-55°C
2
Labelled & Label free assays with:
480 nm, 640 nm or 280 nm LED detectors
4
1
An autosampler 
2 x 96 well plates & 2 x 50 vials
3
Wide sensitivity range: picomolar to millimolar
2
Temperature controls:
  • Autosampler 5-55
  • Capillary chamber 10-45
4
Labelled & Label free assays with:
480 nm, 535 nm, 640nm or 280nm LED detectors
text-left-midtext-left-midtext-midtext-mid
product-fida-bg
text-midtext-left-midtext-midtext-left-mid

Free yourself

No immobilisationIn-solution nature of FIDA allows for access to all binding sites - no more non-specific binding issues.
No constrainsCrude or purified samples, any pH, ionic strength limits, detergents or buffers.
No regenerationEliminates risk of denaturing immobilised protein. Allows for fast determination of slow off rates for high affinity interactions.

Stay in control

Flexible Assay DesignAdjust interaction times for kon/koff measurement; modulate mixing time through in-capillary sample mobilisation.
Embedded Quality Control ReportingFull transparency of sample material quality thanks to embedded Quality Control Module & Reporting Tool.
Detect Strong & Weak BindersCapable of measuring kinetics of both strong and weak interactions in-solution.

Boost Efficiency

Small sample volumes With as little as 4 uL analyte with fixed 40 nL indicator. Save material & effort.
No purificationMinimise assay development time and expands the range of possible biological systems to be characterised.
No time wastedRun 4 minute long assays & take informed decisions thanks to high data transparency.
Label-free or labelledHave an an option of switching detectors while using a single base instrument.
No expert requirementsWith just a few hour of training all scientists can run FIDA experiments.
Small sample volumes With as little as 4 uL analyte with fixed 40 nL indicator. Save material & effort.
No purificationMinimise assay development time and expands the range of possible biological systems to be characterised.
No time wastedRun 4 minute long assays & take informed decisions thanks to high data transparency.
Label-free or labelledHave an an option of switching detectors while using a single base instrument.
No expert requirementsWith just a few hour of training all scientists can run FIDA experiments.

Quality Control Reportingfor every sample

Absolute size

As a firm reference point

Aggregation

Fully Visible

Stickiness

Revealed

Sample Loss

Revealed

Viscocity

Tells you about homogeneity

Polydispersity Index

Tells you about homogeneity

PDB Correlator

Link size with structural data.

Labelling quality

Quantified

How FIDA works, explained.

Learn More about FIDA Technology

Your laboratory instruments should serve you, not the other way around. We're happy to help you.

Who uses Fida?

Who uses Fida?

This methodology is very sensitive and useful for assessing binding in a quantitative manner using small amounts of auto-fluorescent proteins. Using this method, we can observe clear changes in apparent hydrodynamic radius (Rh) and in fluorescence signal of EYA1 as a function of increasing concentrations of peptides or of small molecules

Dana Farber Institute
CANCER INSTITUTE

''Fida  Instrument provides a ''ruler'' to measure the length of fibrils''

Stefan Rüdiger Ph.D.
Professor of Protein Chemistry of Disease; Head of Department of Chemistry

''The FIDA is very effective for screening small molecules for solubility and interactions with protein targets. A major advantage has been its ability to clearly show drug binding to difficult-to-work-with targets such as intrinsically disordered proteins and amyloids''

Dr. Alexander Taylor
Research Fellow in Biochemistry/Biophysics

I would say that this instrument is quite useful for core facilities at KI or for Swedish research community in general:

  1. it was possible to measure unlabeled membrane proteins and soluble proteins at low concentrations in small volumes very fast (~6 minutes per measurement).
  2. I also like the temperature control and the autosampler which allowed us to run a lot of samples overnight.
  3. I would say that there is a lot of potential to perform other assays as well, such as the Kd determinations etc. (For this, I use ITC which is quite time-consuming and requires a lot of protein).
  4. In addition, the software and user interface for sample runs and data analysis is quite straightforward and intuitive to use.
Postdoctoral Researcher

"What we value about FIDA is the amount of information we can get from a tiny amount of protein in a single QC run. FIDA technology enables us to understand our proteins better - particularly when they behave in unexpected ways. We chose FIDA because it gives us that vital first result quickly - we don't waste our time optimising an assay that isn't going to work."

Duncan Smith
Lead Scientist

"I am convinced. I have never before been able to detect the ternary construct formation of my construct directly in cell lysate – it took less than two hours."

Thomas Smith
Associate Director, Chemical Biology & Therapeutics

"The Fida 1’s unique capability for measuring binding Kd from weak mM level to strong pM level really enhances our bioanalytical capabilities."

Sherry Zhu
Senior Scientist

"FIDA is an in-solution technique, and thus an ideal binding assay for structurally diverse bsAbs because the analysis does not rely on potentially obstructive surface immobilization and hence it is able to perform characterizations that are unbiased by bsAb format and spatial orientation of the binding domains."

Andreas V. Madsen
PhD Student

"After thorough comparisons, it was clear that the Fida 1, amongst others, presents unique opportunities in analysis of membrane proteins, which is essential to us."

Svend Kjæer
STP Deputy

''The Fida 1 system offers a new approach to detergent screening that has significant advantages allowing essential data to be obtained faster using less material (…) this work presents a new approach to characterize membrane proteins that allows users to reducing costs and time as well as to analyze protein expressed at low levels in a short time thus overcoming any stability issues.''

Isabel Moraes
Principal Research Scientist

"I like the ease of use and the straightforward data analysis and, that experiments can be performed in any type of buffers. We get data, where no other biophysical methods worked before."

Cathrine Birck
Head of Integrated Structural Biology Platform

"The method is easy to setup in any standard laboratory and can be adopted for a high throughput (HTTP) screening, which enabled mechanistic studies of RNA nuclease interactions, as well as efficient guide RNA lead discovery (…) Fida 1 offers straightforward assay development, walk away automation, absolute measurement and ultra low sample consumption."

Denny Truong
Principal Research Associate

"FIDA provides in-depth assessment of activity combined with local and global protein structural changes by measuring the overall hydrodynamic radius of the protein with minimal sample consumption. In addition, it is possible to measure the affinity constant for the analyzed interaction."

Dr. Melanie Hug
Research Associate

"The beauty of Fida 1 is that it allows us to conduct a lot of biophysical measurements in one system using a small amount of reagent and a rapid read-out time which is important for our projects and to our customers. (…) Providing a high-quality, protein characterisation QC package is certainly extending and future proofing our capabilities in biophysical characterisation of the proteins we produce."

Mark Abbott
Managing Director

"The Fida 1 has allowed us to assess the performance of MIPs with a much higher throughput than was previously possible on other platforms. MIPs can be developed in as little as 8 weeks, which is a significant improvement on antibodies, and now they can be fully characterized at an accelerated pace too."

Alan Thomson
CEO

"Fida 1 can be used for full characterization of ternary complex formation for targeted protein degradation. The Fida 1 platform only consumes 39 nL of sample for one measurement and thus allows elaborate condition screening using very small amounts of sample material."

Roman Agafonov
Associate Director of Biochemistry, Biophysics & Structural Biology

"The Fida1 is a very user-friendly system. With the Fida software we can quickly design new methods, set up experiments, and analyze data. By far this is a great instrument and technology that has allowed us to run binding assays for LNP in solution and with flexibility to run in any complex media which we were unable to do using traditional binding methods that required ligand immobilization. The FidaBio customer service is amazing, they are very knowledgeable and responsive whenever I run into issues and need assistance. I highly recommend this instrument for LNP or any other nanoparticle characterization. The system and technology are versatile with applications beyond nanoparticles and is a must in the biophysical tool kit."

Biophysical Analytical Department
Senior Scientist, Analytical Development

"Eventually, with FIDA, we managed to characterise our LNPs. And it was done in less than 2 days. We had for a long time been struggling with SPR."

Chemical Biology and Therapeutics
Associate Director

"We had been looking for ways of quantifying our exosomes, and tested many platform, without success. In less than 2 days FIDA had developed an assay and shown trustworthy quantifications directly in fermentation broth"

Rane Harrison
Director, Analytical Development